ASAH2 prevents the accumulation of ceramides through the sphingolipid metabolism hydrolyzing ceramides pathway [85], which has been shown to be associated with AD neurological pathologies, and consequently affects cognitive function [86]. Here, ASAH2 is linked to Alzheimer disease.